Huawei Chen
Impact in
- Pharmacology top 0.5%
- Microbial Natural Products and Biosynthesis
- Molecular Biology top 5%
- Epigenetics and DNA Methylation
- Protein Degradation and Inhibitors
- Cancer-related gene regulation
- Genomics and Phylogenetic Studies
- DNA Repair Mechanisms
- Chemical Synthesis and Analysis
Papers in
-
- Epigenetics and DNA Methylation 7
- Cancer-related gene regulation 6
- Protein Degradation and Inhibitors 6
- Pharmacology 12
- Microbial Natural Products and Biosynthesis 11
- Co-authors
- Christopher T. Walsh (9 shared papers)Brian K. Hubbard (5 shared papers)Christopher T. Walsh (1 shared paper)Sarah E. O’Connor (4 shared papers)Steven X. Hou (4 shared papers)Heather C. Losey (2 shared papers)Jiaquan Wu (6 shared papers)Wei‐Mei Ching (7 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (4 papers)Cancer Research (4 papers)Biochemistry (4 papers)PLoS ONE (3 papers)Journal of the American Chemical Society (3 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Huawei Chen
80 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 108
- Pharmacology 809
- Molecular Biology 2.0k
- Biotechnology 248
- Oncology 379
- Organic Chemistry 407
Countries citing papers authored by Huawei Chen
This map shows the geographic impact of Huawei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huawei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huawei Chen more than expected).
Fields of papers citing papers by Huawei Chen
This network shows the impact of papers produced by Huawei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huawei Chen. The network helps show where Huawei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Huawei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 231 | |
| 2 | 2018 | 211 | |
| 3 | 2011 | 156 | |
| 4 | 2001 | 142 | |
| 5 | 2002 | 137 | |
| 6 | 2002 | 122 | |
| 7 | 2012 | 120 | |
| 8 | 2003 | 109 | |
| 9 | 2012 | 98 | |
| 10 | 2000 | 89 | |
| 11 | 2013 | 87 | |
| 12 | 2012 | 85 | |
| 13 | 2001 | 85 | |
| 14 | 2003 | 78 | |
| 15 | 2018 | 68 | |
| 16 | 2001 | 65 | |
| 17 | 2019 | 65 | |
| 18 | 2002 | 62 | |
| 19 | 2001 | 58 | |
| 20 | 2010 | 54 |
About Huawei Chen
Huawei Chen is a scholar working on Molecular Biology, Pharmacology, Oncology, Infectious Diseases and Public Health, Environmental and Occupational Health, having authored 84 papers that have together received 3.0k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (11 papers), Epigenetics and DNA Methylation (7 papers), Mosquito-borne diseases and control (7 papers), Biosensors and Analytical Detection (6 papers), Cancer-related gene regulation (6 papers), Protein Degradation and Inhibitors (6 papers), Vector-borne infectious diseases (5 papers) and Cancer Mechanisms and Therapy (5 papers). The work is most often cited by research in Pharmacology (809 citations), Molecular Biology (2.0k citations), Biotechnology (248 citations), Oncology (379 citations) and Organic Chemistry (407 citations). Huawei Chen has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Christopher T. Walsh, Brian K. Hubbard, Christopher T. Walsh, Sarah E. O’Connor, Steven X. Hou, Heather C. Losey, Jiaquan Wu, Wei‐Mei Ching, María Julia Marinissen and J. Silvio Gutkind. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cancer Research, Biochemistry, PLoS ONE and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.